Results 1 to 10 of about 16,458 (236)

Sounding out falsified medicines from genuine medicines using Broadband Acoustic Resonance Dissolution Spectroscopy (BARDS) [PDF]

open access: yesScientific Reports, 2021
The trade in falsified medicine has increased significantly and it is estimated that global falsified sales have reached $100 billion in 2020. The EU Falsified Medicines Directive states that falsified medicines do not only reach patients through illegal
Anas Alfarsi   +9 more
doaj   +2 more sources

Estimated prevalence of unregistered and falsified medicinal products in Malaysia: a nationwide cross-sectional study conducted from March to November 2023 [PDF]

open access: yesJournal of Pharmaceutical Policy and Practice
Background The global proliferation of unregistered and falsified medicinal products poses significant public health risks. In Malaysia, previous studies have shown concerning prevalence rates but are often limited to specific populations and targeted ...
Khairul Anuar Abdul Karim   +6 more
doaj   +2 more sources

Knowledge, attitudes and practices on substandard and falsified medicines for human and animal use in Wakiso district, Uganda [PDF]

open access: yesJournal of Pharmaceutical Policy and Practice
Background Substandard and falsified medicines (SFMs) continue to pose a significant threat to public health globally. However, there is limited evidence on use of SFMs for both humans and animals particularly in low- and middle-income countries such as ...
David Musoke   +11 more
doaj   +2 more sources

Biochemical profiling provides a low-cost and globally accessible method to detect falsified vaccines and insulin [PDF]

open access: yesScientific Reports
For many decades, there have been numerous reported cases of falsified liquid medical products, including vaccine and insulin preparations worldwide, but to date, there has been a lack of affordable and accessible analytical methods for biological ...
Jennifer Brook   +27 more
doaj   +2 more sources

Prevalence of substandard, falsified, unlicensed and unregistered medicine and its associated factors in Africa: a systematic review

open access: yesJournal of Pharmaceutical Policy and Practice
Background: Substandard, falsified, unlicensed, and unregistered medicines pose significant risks to public health in developed and developing countries. This systematic review provides an overview of the prevalence of substandard, falsified, unlicensed,
Biset Asrade Mekonnen   +1 more
exaly   +3 more sources

Assessing the quality of antimalarial drugs in Equatorial Guinea: a follow-up study [PDF]

open access: yesBMJ Global Health
Introduction Poor-quality antimalarial medications, including falsified and substandard formulations, pose significant public health risks, contributing to ineffective treatment and potential drug resistance.
Harparkash Kaur   +8 more
doaj   +2 more sources

Perception of falsified and counterfeit medicines among adults living in Mexico City and the metropolitan area: an underappreciated health risk [PDF]

open access: yesFrontiers in Pharmacology
Falsified and counterfeit medicines represent a growing global public health concern and straddles business implications, and their proliferation has intensified worldwide.
Jessica Citlalli Celaya Pérez   +7 more
doaj   +2 more sources

The role of pharmacists in eliminating counterfeit medicines in Nigeria

open access: yesFrontiers in Public Health, 2023
IntroductionOver the years, counterfeit pharmaceuticals have posed immense concerns for global health and patient safety. This menace encompasses various classes of medications. Given the criticality of pharmacists’ interventions in drug distribution and
Obi Peter Adigwe
doaj   +1 more source

Pharmacists’ perceptions and attitudes toward drug importation into the State of Florida

open access: yesJournal of Pharmaceutical Policy and Practice, 2021
Background The Department of Health and Human Services and the Food and Drug Administration released the Safe Importation Action Plan in July 2020 detailing methods to import medicines from Canada to combat increasing drug costs.
John B. Hertig   +2 more
doaj   +1 more source

A simplified checklist for the visual inspection of finished pharmaceutical products: a way to empower frontline health workers in the fight against poor-quality medicines

open access: yesJournal of Pharmaceutical Policy and Practice, 2020
Background Substandard and falsified medicines, mainly prevalent in low and middle-income countries (LMICs), cause avoidable morbidity and mortality, and put at stake the performance of health systems.
B. Schiavetti   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy